Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study

Neuroscience

Volumn 310, Issue , 2015, Pages 442-454

  Helboe, L ^a   Egebjerg, J ^a   de Jong, I E M ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 HT6 receptor; Alzheimer's disease; In situ hybridization; Interneuron; Pyramidal cell; Rat

Indexed keywords

CALBINDIN; CALRETININ; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; NEUROPEPTIDE Y; PARVALBUMIN; SEROTONIN 3A RECEPTOR; SEROTONIN 6 RECEPTOR; SOMATOSTATIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VESICULAR GLUTAMATE TRANSPORTER 1; 4 AMINOBUTYRIC ACID RECEPTOR; SEROTONIN RECEPTOR;

ADULT; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CELL SUBPOPULATION; CENTRAL GRAY MATTER; CEREBELLUM; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENTORHINAL CORTEX; FOREBRAIN; GABAERGIC SYSTEM; GLOBUS PALLIDUS; GLUTAMATERGIC NEURON; HABENULA; HIPPOCAMPUS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; INTERNEURON; LOCUS CERULEUS; MEYNERT BASAL NUCLEUS; NEOCORTEX; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NERVOUS SYSTEM; OLFACTORY TUBERCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PUTAMEN; PYRIFORM CORTEX; RAPHE NUCLEUS; RAT; SEPTUM PELLUCIDUM; SEROTONINERGIC NERVE CELL; STRIA TERMINALIS; SUBICULUM; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS; VENTRAL TEGMENTUM; ANIMAL; BRAIN; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN; CEREBRAL CORTEX; GABAERGIC NEURONS; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INTERNEURONS; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RNA, MESSENGER;

EID: 84943759165     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.09.064     Document Type: Article

References (78)

1. Arnt J., Bang-Andersen B., Grayson B., Bymaster F.P., Cohen M.P., DeLapp N.W., Giethlen B., Kreilgaard M., McKinzie D.L., Neill J.C., Nelson D.L., Nielsen S.M., Poulsen M.N., Schaus J.M., Witten L.M. Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats. Int J Neuropsychopharmacol 2010, 13:1021-1033.
2. Arroyo S., Bennett C., Aziz D., Brown S.P., Hestrin S. Prolonged disynaptic inhibition in the cortex mediated by slow, non-alpha7 nicotinic excitation of a specific subset of cortical interneurons. J Neurosci 2012, 32:3859-3864.
3. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69.
4. Benhamu B., Martin-Fontecha M., Vazquez-Villa H., Pardo L., Lopez-Rodriguez M.L. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease. J Med Chem 2014, 57:7160-7181.
5. Bennett B.D., Bolam J.P. Two populations of calbindin D28k-immunoreactive neurones in the striatum of the rat. Brain Res 1993, 610:305-310.
6. Blatow M., Rozov A., Katona I., Hormuzdi S.G., Meyer A.H., Whittington M.A., Caputi A., Monyer H. A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 2003, 38:805-817.
7. Bourson A., Boess F.G., Bos M., Sleight A.J. Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 1998, 125:1562-1566.
8. Bradfield L.A., Bertran-Gonzalez J., Chieng B., Balleine B.W. The thalamostriatal pathway and cholinergic control of goal-directed action: interlacing new with existing learning in the striatum. Neuron 2013, 79:153-166.
9. Caputi A., Rozov A., Blatow M., Monyer H. Two calretinin-positive GABAergic cell types in layer 2/3 of the mouse neocortex provide different forms of inhibition. Cereb Cortex 2009, 19:1345-1359.
10. Chittajallu R., Craig M.T., McFarland A., Yuan X., Gerfen S., Tricoire L., Erkkila B., Barron S.C., Lopez C.M., Liang B.J., Jeffries B.W., Pelkey K.A., McBain C.J. Dual origins of functionally distinct O-LM interneurons revealed by differential 5-HT(3A)R expression. Nat Neurosci 2013, 16:1598-1607.
11. Cruikshank S.J., Ahmed O.J., Stevens T.R., Patrick S.L., Gonzalez A.N., Elmaleh M., Connors B.W. Thalamic control of layer 1 circuits in prefrontal cortex. J Neurosci 2012, 32:17813-17823.
12. Dawson L.A. The central role of 5-HT6 receptors in modulating brain neurochemistry. Int Rev Neurobiol 2011, 96:1-26.
13. Dawson L.A., Nguyen H.Q., Li P. In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 2000, 130:23-26.
14. Dawson L.A., Nguyen H.Q., Li P. The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 2001, 25:662-668.
15. de Bruin N.M., Prickaerts J., van L.A., Venhorst J., de G.L, Houba P., Reneerkens O., Akkerman S., Kruse C.G. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 2011, 96:392-402.
16. de Bruin N.M., McCreary A.C., van L.A., de Vries T.J., Venhorst J., van D.M., Kruse C.G. A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats. Behav Brain Res 2013, 236:157-165.
17. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 1997, 14:1-19.
18. del Rio M.R., DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J Neurosci 1997, 17:5143-5154.
19. Di C.G., Valentini V., Fenu S. Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement. Int Rev Neurobiol 2011, 96:111-139.
20. 125I]SB-258585. Synapse 2002, 45:191-199.
21. Eskenazi D., Neumaier J.F. Increased expression of the 5-HT6 receptor by viral mediated gene transfer into posterior but not anterior dorsomedial striatum interferes with acquisition of a discrete action-outcome task. J Psychopharmacol 2011, 25:944-951.
22. Ferezou I., Cauli B., Hill E.L., Rossier J., Hamel E., Lambolez B. 5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons. J Neurosci 2002, 22:7389-7397.
23. Fone K.C. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function. Neuropharmacology 2008, 55:1015-1022.
24. Foraster M.A., Herrik K.F., Richard N., Bastlund J.F., de Jong I.E.M., Smagin G., Mørk A. The 5-HT6 receptor antagonist LU AE58054 alone and in combination with donepezil potentiates gamma oscillations in rat medial prefrontal cortex. Alz Dement 2014, 10:P780-P781. ABSTRACT.
25. Fremeau R.T., Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellocchio E.E., Fortin D., Storm-Mathisen J., Edwards R.H. The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 2001, 31:247-260.
26. Gerard C., el M.S., Lebrand C., Adrien J., Ruat M., Traiffort E., Hamon M., Martres M.P. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 1996, 23:164-173.
27. Gonchar Y., Burkhalter A. Connectivity of GABAergic calretinin-immunoreactive neurons in rat primary visual cortex. Cereb Cortex 1999, 9:683-696.
28. Goutagny R., Krantic S. Hippocampal oscillatory activity in Alzheimer's disease: toward the identification of early biomarkers?. Aging Dis 2013, 4:134-140.
29. Gulyas A.I., Freund T.F. Pyramidal cell dendrites are the primary targets of calbindin D28k-immunoreactive interneurons in the hippocampus. Hippocampus 1996, 6:525-534.
30. Gulyas A.I., Hajos N., Freund T.F. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci 1996, 16:3397-3411.
31. Hart G., Leung B.K., Balleine B.W. Dorsal and ventral streams: the distinct role of striatal subregions in the acquisition and performance of goal-directed actions. Neurobiol Learn Mem 2014, 108:104-118.
32. Heal D., Gosden J., Smith S. The 5-HT6 receptor as a target for developing novel antiobesity drugs. Int Rev Neurobiol 2011, 96:73-109.
33. Herrik K.F., Richard N., Garmer M., Bastlund J.F., de Jong I., Mørk A. The 5-HT6 antagonist LU AE58054 potentiates the effect of acetylcholinesterase inhibition on extracellular acetylcholine levels and oscillatory activity in the rat dorsal hippocampus. Alz Dement 2014, 10:P780. ABSTRACT.
34. Hirst W.D., Abrahamsen B., Blaney F.E., Calver A.R., Aloj L., Price G.W., Medhurst A.D. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 2003, 64:1295-1308.
35. Huang Y., Yoon K., Ko H., Jiao S., Ito W., Wu J.Y., Yung W.H., Lu B., Morozov A. 5-HT3a receptors modulate hippocampal gamma oscillations by regulating synchrony of parvalbumin-positive interneurons. Cereb Cortex 2014.
36. Ingram S.M., Krause R.G., Baldino F., Skeen L.C., Lewis M.E. Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization histochemistry. J Comp Neurol 1989, 287:260-272.
37. 6 receptor agonists. J Med Chem 2015, 10.1021/acs.jmedchem.5b00179.
38. Kendall I., Slotten H.A., Codony X., Burgueno J., Pauwels P.J., Vela J.M., Fone K.C. E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. Psychopharmacology 2011, 213:413-430.
39. Lacroix L.P., Dawson L.A., Hagan J.J., Heidbreder C.A. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 2004, 51:158-164.
40. Lee S., Hjerling-Leffler J., Zagha E., Fishell G., Rudy B. The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J Neurosci 2010, 30:16796-16808.
41. Lein E.S., Zhao X., Gage F.H. Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci 2004, 24:3879-3889.
42. Lorke D.E., Lu G., Cho E., Yew D.T. Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients. BMC Neurosci 2006, 7:36.
43. Ly S., Pishdari B., Lok L.L., Hajos M., Kocsis B. Activation of 5-HT6 receptors modulates sleep-wake activity and hippocampal theta oscillation. ACS Chem Neurosci 2013, 4:191-199.
44. Maher-Edwards G., Dixon R., Hunter J., Gold M., Hopton G., Jacobs G., Hunter J., Williams P. SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. Int J Geriatr Psychiatry 2011, 26:536-544.
45. Marazziti D., Baroni S., Pirone A., Giannaccini G., Betti L., Testa G., Schmid L., Palego L., Borsini F., Bordi F., Piano I., Gargini C., Castagna M., Catena-Dell'osso M., Lucacchini A. Serotonin receptor of type 6 (5-HT6) in human prefrontal cortex and hippocampus post-mortem: an immunohistochemical and immunofluorescence study. Neurochem Int 2013, 62:182-188.
46. Marcos B., Gil-Bea F.J., Hirst W.D., Garcia-Alloza M., Ramirez M.J. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 2006, 24:1299-1306.
47. Marcos B., Chuang T.T., Gil-Bea F.J., Ramirez M.J. Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Br J Pharmacol 2008, 155:434-440.
48. Margolis E.B., Toy B., Himmels P., Morales M., Fields H.L. Identification of rat ventral tegmental area GABAergic neurons. PLoS One 2012, 7:e42365.
49. Meneses A. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative. Rev Neurosci 2014, 25:325-356.
50. Meneses A., Perez-Garcia G., Ponce-Lopez T., Castillo C. 5-HT6 receptor memory and amnesia: behavioral pharmacology-learning and memory processes. Int Rev Neurobiol 2011, 96:27-47.
51. Mitchell E.S., Neumaier J.F. 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 2005, 108:320-333.
52. Mitchell E.S., Sexton T., Neumaier J.F. Increased expression of 5-HT6 receptors in the rat dorsomedial striatum impairs instrumental learning. Neuropsychopharmacology 2007, 32:1520-1530.
53. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993, 43:320-327.
54. Monti J.M., Jantos H., Schechter L.E. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat. Behav Brain Res 2013, 249:65-74.
55. Morales M., Bloom F.E. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci 1997, 17:3157-3167.
56. Morales M., Hein K., Vogel Z. Hippocampal interneurons co-express transcripts encoding the alpha7 nicotinic receptor subunit and the cannabinoid receptor 1. Neuroscience 2008, 152:70-81.
57. Ohno Y., Imaki J., Mae Y., Takahashi T., Tatara A. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors. Neuropharmacology 2011, 60:201-208.
58. Olah S., Fule M., Komlosi G., Varga C., Baldi R., Barzo P., Tamas G. Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 2009, 461:1278-1281.
59. Palmer L.M., Schulz J.M., Murphy S.C., Ledergerber D., Murayama M., Larkum M.E. The cellular basis of GABA(B)-mediated interhemispheric inhibition. Science 2012, 335:989-993.
60. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
61. Parker C.A., Gunn R.N., Rabiner E.A., Slifstein M., Comley R., Salinas C., Johnson C.N., Jakobsen S., Houle S., Laruelle M., Cunningham V.J., Martarello L. Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor. J Nucl Med 2012, 53:295-303.
62. Perrenoud Q., Rossier J., Ferezou I., Geoffroy H., Gallopin T., Vitalis T., Rancillac A. Activation of cortical 5-HT(3) receptor-expressing interneurons induces NO mediated vasodilatations and NPY mediated vasoconstrictions. Front Neural Circuits 2012, 6:50.
63. Ramirez M.J. 5-HT6 receptors and Alzheimer's disease. Alzheimers Res Ther 2013, 5:15.
64. Reznic J., Staubli U. Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J Neurophysiol 1997, 77:517-521.
65. 125I]SB-258585. Brain Res 2002, 934:49-57.
66. Ruat M., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Diaz J., Leurs R., Schwartz J.C. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 1993, 193:268-276.
67. Rudy B., Fishell G., Lee S., Hjerling-Leffler J. Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons. Dev Neurobiol 2011, 71:45-61.
68. Schechter L.E., Lin Q., Smith D.L., Zhang G., Shan Q., Platt B., Brandt M.R., Dawson L.A., Cole D., Bernotas R., Robichaud A., Rosenzweig-Lipson S., Beyer C.E. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 2008, 33:1323-1335.
69. Shukla R., Watakabe A., Yamamori T. MRNA expression profile of serotonin receptor subtypes and distribution of serotonergic terminations in marmoset brain. Front Neural Circuits 2014, 8:52.
70. Staubli U., Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 1995, 15:2445-2452.
71. Tamas G., Lorincz A., Simon A., Szabadics J. Identified sources and targets of slow inhibition in the neocortex. Science 2003, 299:1902-1905.
72. Tassone A., Madeo G., Schirinzi T., Vita D., Puglisi F., Ponterio G., Borsini F., Pisani A., Bonsi P. Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. Neuropharmacology 2011, 61:632-637.
73. Valentini V., Piras G., De Luca M.A., Perra V., Bordi F., Borsini F., Frau R., Di C.G. Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement. Neuropharmacology 2013, 65:58-64.
74. Ward R.P., Dorsa D.M. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J Comp Neurol 1996, 370:405-414.
75. Wesolowska A., Jastrzebska-Wiesek M. Behavioral pharmacology: potential antidepressant and anxiolytic properties. Int Rev Neurobiol 2011, 96:49-71.
76. Wilkinson D., Windfeld K., Colding-Jorgensen E. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 2014, 13:1092-1099.
77. Woolley M.L., Marsden C.A., Fone K.C. 5-HT6 receptors. Curr Drug Targets CNS Neurol Disord 2004, 3:59-79.
78. Zhang X., Andren P.E., Glennon R.A., Svenningsson P. Distribution, level, pharmacology, regulation, and signaling of 5-HT6 receptors in rats and marmosets with special reference to an experimental model of parkinsonism. J Comp Neurol 2011, 519:1816-1827.